Nurix Therapeutics | 8-K: Current report
Apr 13 05:14
Nurix Therapeutics | 424B5: Prospectus
Apr 13 05:13
Nurix Therapeutics | 424B5: Prospectus
Apr 12 04:11
Nurix Therapeutics | 10-Q: Quarterly report
Apr 10 19:07
Nurix Therapeutics | 8-K: Current report
Apr 10 19:07
Nurix Therapeutics | 8-K: Current report
Apr 10 01:20
Nurix Therapeutics | ARS: Annual Report to Security Holders
Mar 27 19:08
Nurix Therapeutics | DEFA14A: Others
Mar 27 19:04
Nurix Therapeutics | DEF 14A: Definitive information statements
Mar 27 19:04
Nurix Therapeutics | 8-K: Current report
Mar 11 19:06
Nurix Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer van Houte Hans
Feb 17 08:22
Nurix Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Feb 17 05:29
Nurix Therapeutics | 10-K: Annual report
Feb 16 11:20
Nurix Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Feb 16 05:53
Nurix Therapeutics | 8-K: Current report
Feb 16 05:03
Nurix Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer van Houte Hans
Feb 15 20:27
Nurix Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Ring Christine
Feb 15 20:27
Nurix Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hansen Gwenn
Feb 15 20:27
Nurix Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer SANDS ARTHUR T
Feb 15 20:27
Nurix Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Baker Bros. Advisors LP(9.99%),Baker Bros. Advisors (GP) LLC(9.99%), etc.
Feb 15 06:46
No Data
No Data